Tuberculous Pleural Effusion

2

Review clinical trials related to Tuberculous Pleural Effusion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of Intrapleural Fibrinolytic Therapy in Tuberculous Pleural Effusion Versus Non-Tuberculous Pleural Infection

This retrospective cohort study evaluates the efficacy and safety of intrapleural fibrinolytic therapy (tPA/DNase) in patients with tuberculous pleural effusion compared with non-tuberculous pleural infection at Hospital Canselor Tuanku Muhriz (HCTM), Malaysia. The study aims to compare radiological improvement, clinical outcomes, and treatment-related adverse events to provide evidence supporting the use of IPFT in tuberculous pleural effusion.

Participants needed: 160
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: National University of MalaysiaUpdated: Sep 16, 2026Locations: 1
Eligibility criteria

Adults aged ≥18 years. [+2]

Malignant and transudative pleural effusion [+2]

Status: Not yet recruiting

Cancer Ratio and Cancer Ratio Plus in Malignant and Tuberculous Pleural Effusions

This prospective observational analytical study aims to assess the diagnostic value of Cancer Ratio and Cancer Ratio Plus in differentiating malignant pleural effusion from tuberculous pleural effusion. Adult patients with confirmed malignant or tuberculous pleural effusion will be recruited from the Chest Diseases Department, Sohag University Hospitals. Clinical, laboratory, and radiological data will be collected, and the diagnostic performance of both markers will be evaluated.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Sohag UniversityUpdated: Aug 17, 2026
Eligibility criteria

Adult patients (≥18 years) [+2]

Patients with mixed etiology effusions (e.g., malignancy with infection) [+2]